Value of Real Time Three‐Dimensional Echocardiography in Patients with Hypertrophic Cardiomyopathy: Comparison with Two‐Dimensional Echocardiography and Magnetic Resonance Imaging

Bicudo, Letícia; Tsutsui, Jeane Mike; Shiozaki, Afonso Akio; Rochitte, Carlos Eduardo; Arteaga, Edmundo; Mady, Charles; Ramires, José Antônio Franchini; Mathias, Wilson

doi:10.1111/j.1540-8175.2008.00684.x

Cited by 66 publications

(48 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…85 LEOPARD (lentigines, ECG abnormalities, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, growth retardation, and deafness) syndrome shares many features with Noonan syndrome and is also caused by mutations in the PTPN11 gene. 23 Noonan syndrome and LEOPARD syndrome are examples of neurocardio-facial-cutaneous syndromes. Many are caused by germline mutations in key components of the highly conserved RAS-MAPK cascade.…”

Section: Desai Et Al Hypertrophic Cardiomyopathy 161mentioning

confidence: 99%

“…Three-dimensional echocardiography quantifies and characterizes myocardial hypertrophy, LV volumes, LV ejection fraction, and LV mass more accurately than traditional 2D echocardiography. 23 Cardiac magnetic resonance (CMR) is especially useful in identifying the varied phenotypic presentations of HCM, particularly when hypertrophy involves the anterolateral free wall 24 and apical variant, 25 which often are poorly visualized on echocardiography. In 1 study, 24 CMR accurately identified HCM missed on echocardiography in 6% of the patients.…”

Section: Geometrymentioning

confidence: 99%

See 1 more Smart Citation

Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy

Desai

Ommen

McKenna

et al. 2011

Circ: Cardiovascular Imaging

View full text Add to dashboard Cite

H ypertrophic cardiomyopathy (HCM) is a common monogenetic cardiac disease with a prevalence of 0.2% 1 that usually is inherited as an autosomal dominant trait with variable penetrance and expression. Clinically, HCM is defined by the presence of left ventricular (LV) hypertrophy (LVH) unexplained by abnormal loading conditions. 1 The natural history varies from an asymptomatic course to drugrefractory angina/dyspnea, sudden cardiac death (SCD), and end-stage heart failure. The incidence of HCM-related SCD is approximately 1% to 2% in children and adolescents and 0.5% to 1% in adults. 2,3 In this review, we examine the impact of advanced diagnostic imaging technologies on HCM, with particular emphasis on the detection of particular genetic subtypes.

show abstract

Section: Desai Et Al Hypertrophic Cardiomyopathy 161mentioning

confidence: 99%

Section: Geometrymentioning

confidence: 99%

Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy

Desai

Ommen

McKenna

et al. 2011

Circ: Cardiovascular Imaging

View full text Add to dashboard Cite

show abstract

“…The 3D echocardiographic assessment of LV volumes and function provides accuracies that approach the accuracy of cardiac magnetic resonance imaging (cMRI) [6][7][8][9][10][11][12][13][14]. Furthermore, 3D echocardiography for the assessment of LV volumes and ejection fraction (EF) has been currently recommended over the use of 2D echocardiography, due to its accuracy and reproducible measurements [13,14].…”

Section: Assessment Of the Left Ventriclementioning

confidence: 99%

Evolving Role of Three-Dimensional Echocardiography in the Cardiac Surgical Patient

Ferreira

Choi

Mackensen

2013

Curr Anesthesiol Rep

View full text Add to dashboard Cite

The first human three-dimensional transesophageal echocardiography (3D TEE) was reported in 1992. Ever since, technologic advances have revolutionized this echocardiographic imaging modality. Today, real-time 3D TEE (RT-3D TEE) represents a novel clinical and intuitively educational perioperative cardiovascular imaging tool. In addition, live 3D TEE adds significantly to the perioperative communication between cardiac surgeons and echocardiographer. Its unique ability of real-time acquisition and accurate identification of precise cardiac pathology, together with its ability to promptly quantify 3D datasets using builtin software, has greatly helped to transition 3D TEE into the standard of perioperative care. The recent development of percutaneous procedures such as valve implantations and repairs also benefit from 3D TEE quantification and guidance. This article reviews the available 3D TEE acquisition modes, newest advances in 3D technology, and the utility of 3D TEE in different settings of cardiac procedures.

show abstract

“…The real-time three-dimensional echocardiography allows detailed evaluation of the morphological changes undergone by the LV in HCM, with performance comparable to MRI and notably better than two-dimension echocardiography 63 .…”

Section: Three-dimensional Echocardiographymentioning

confidence: 99%

O diagnóstico da obstrução da via de saída do ventrículo esquerdo na cardiomiopatia hipertrófica

Mattos¹,

Torres²,

Rebelatto³

et al. 2012

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Hypertrophic cardiomyopathy is a prevalent genetic disease characterized by left ventricular hypertrophy, presenting dynamic obstruction of outflow tract with subaortic gradient happening at rest in 30% of the cases. It is attributed to the intricate interaction between the anterior mitral leaflet, the interventricular septum and altered flow vectors generated in left ventricle along with changes in outflow tract geometry. Mitral regurgitation in varying degrees is found with or without association with structural deformities of the valve apparatus. The exercise echocardiogram evidences latent obstruction easily induced by exercise in 60 to 75% of nonobstructive forms. The determination of the gradient under this condition must be considered in routine investigation of patients with mild or no obstruction at rest. The evaluation of hypertrophic cardiomyopathy incorporates methods based on the ultrasound image, which, along with MRI, allow recognizing ventricular obstruction generating mechanisms, thus facilitating the diagnosis and management of obstructive and latent obstructive forms.

show abstract

Value of Real Time Three‐Dimensional Echocardiography in Patients with Hypertrophic Cardiomyopathy: Comparison with Two‐Dimensional Echocardiography and Magnetic Resonance Imaging

Abstract: In patients with HCM, RT3DE demonstrated superior performance than 2DE for the evaluation of myocardial hypertrophy, LV volumes, LVEF, and LV mass.

Cited by 66 publications

References 34 publications

Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy

Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy

Evolving Role of Three-Dimensional Echocardiography in the Cardiac Surgical Patient

O diagnóstico da obstrução da via de saída do ventrículo esquerdo na cardiomiopatia hipertrófica

Contact Info

Product

Resources

About